DGAP-News: Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of Immune Evasive Cells

DGAP-News: Kadimastem
Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of Immune Evasive Cells

08.06.2022 / 13:00
The issuer is solely responsible for the content of this announcement.


If the...
Quelle: Börse Online RSS Feed